Pregled bibliografske jedinice broj: 85495
Comparative Analysis of Azithromycin and Clarithromycin Efficacy and Tolerability in the Treatment of Chronic Prostatitis Caused by Chlamydia trachomatis
Comparative Analysis of Azithromycin and Clarithromycin Efficacy and Tolerability in the Treatment of Chronic Prostatitis Caused by Chlamydia trachomatis // Journal of Chemotherapy, 14 (2002), 4; 384-389 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 85495 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Comparative Analysis of Azithromycin and Clarithromycin Efficacy and Tolerability in the Treatment of Chronic Prostatitis Caused by Chlamydia trachomatis
Autori
Škerk, Višnja ; Schönwald, Slavko ; Krhen, Ivan ; Markovinović, Leo ; Baršić, Bruno ; Mareković, Ivana ; Roglić, Srđan ; Zeljko, Zvonimir ; Vince, Adriana ; Čajić, Vjeran
Izvornik
Journal of Chemotherapy (1120-009X) 14
(2002), 4;
384-389
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
azithromycin; clarithromycin; prostatitis; Chlamydia trachomatis
Sažetak
A total of 123 patients, older than 18 years of age, with symptoms of chronic prostatitis and inflammatory findings as well as the presence of Chlamydia trachomatis confirmed by DNA/RNA DIGENE hybridization method in expressed prostatic secretion or in voided bladder urine collected immediately after prostatic massage, were examined. The patients were randomized to receive a total of 4.5 g of azithromycin for 3 weeks, given as a 3-day therapy of 1x500 mg weekly or clarithromycin 500 mg b.i.d. for 15 days. Patients' sexual partners were treated at the same time. Clinical and bacteriological efficacy were evaluated 4-6 weeks after the end of therapy. In the group of patients with chronic chlamydial prostatitis the eradication rates (azithromycin 37/46, clarithromycin 36/45) and the clinical cure rates (azithromycin 32/46, clarithromycin 32/45) were not significantly different with regards to the administered drug (p 0.05). In the group of patients with asymptomatic chlamydial prostatitis the eradication rates (azithromycin 11/16, clarithromycin 10/15) were not significantly different with regards to the administered drug (p=1.00, OR=1.1).
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Višnja Škerk
(autor)
Adriana Vince
(autor)
Ivan Krhen
(autor)
Bruno Baršić
(autor)
Zvonimir Mareković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Index Medicus